Sign In
Buy ZTS
$74.57
+0.400 (+0.539%)
At Close: Jul 23, 2026
You Don't Have To Take Excess Risk To Beat The Market
05:59pm, Monday, 25'th Mar 2024
It is possible for retail investors to consistently beat the market by owning above-average blue chip dividend growth stocks. Hard work, research, and staying rational are key factors in outperforming
Zoetis: My Favorite Healthcare Stock Right Now
03:11pm, Thursday, 21'st Mar 2024
Zoetis Inc. has shown unique compounding results since spinning off from Pfizer, with double-digit EPS and dividend growth CAGRs since inception. The loneliness epidemic is driving demand for companio
My Top 15 High Growth Dividend Stocks For March 2024
10:36am, Sunday, 03'rd Mar 2024
The SPDR S&P 500 ETF Trust had a 5.22% return in February, outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares.
Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness
12:55pm, Tuesday, 27'th Feb 2024
Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness
1 Magnificent S&P 500 Dividend Stock Down 23% to Buy Right Now
09:45am, Monday, 26'th Feb 2024
Zoetis is the world's largest producer of medicine and vaccinations for pets and livestock. It's also been incredibly profitable for its shareholders since its spinoff from Pfizer.
5 Dividend Growth Stocks That Outperformed S&P 500 Over 5-Year Rolling Periods
07:34pm, Monday, 19'th Feb 2024
Beating the S&P 500 is difficult due to skewed market returns favoring a few high-performing stocks.
GRFS or ZTS: Which Is the Better Value Stock Right Now?
12:40pm, Wednesday, 14'th Feb 2024
Investors with an interest in Medical - Drugs stocks have likely encountered both Grifols (GRFS) and Zoetis (ZTS). But which of these two stocks offers value investors a better bang for their buck rig
Zoetis CEO Kristin Peck on Q4 earnings
01:11pm, Tuesday, 13'th Feb 2024
Kristin Peck, Zoetis CEO, joins 'Money Movers' to discuss what Zoetis' guidance says about Peck's business expectations, factors that are contributing to their growth relative to fundamentals, and how
Zoetis' (ZTS) Q4 Earnings Miss Expectations, Sales Beat
12:26pm, Tuesday, 13'th Feb 2024
Zoetis (ZTS) reports mixed fourth-quarter results, wherein earnings miss estimates while revenues beat the same.
Compared to Estimates, Zoetis (ZTS) Q4 Earnings: A Look at Key Metrics
11:01am, Tuesday, 13'th Feb 2024
The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimat
Zoetis (ZTS) Q4 Earnings Lag Estimates
09:11am, Tuesday, 13'th Feb 2024
Zoetis (ZTS) came out with quarterly earnings of $1.24 per share, missing the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of $1.15 per share a year ago.
Ahead of Zoetis (ZTS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:21am, Thursday, 08'th Feb 2024
Beyond analysts' top -and-bottom-line estimates for Zoetis (ZTS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter e
Daily Dividend Report: Mastercard, MMM, Gilead, Keurig, Zoetis
03:36pm, Wednesday, 07'th Feb 2024
Mastercard today announced that its Board of Directors has declared a quarterly cash dividend of 66 cents per share. The cash dividend will be paid on May 9, 2024 to holders of record of its Class A c
Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Tuesday, 06'th Feb 2024
Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GRFS or ZTS: Which Is the Better Value Stock Right Now?
12:46pm, Monday, 29'th Jan 2024
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Grifols (GRFS) and Zoetis (ZTS). But which of these two stocks presents investors with the better value op
